Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 166

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 166
---
,000 common shares as part of the share issuance in connection with the RTO, and received 523,561 common shares upon conversion of promissory notes, which were consolidated into 261,780 common shares of the Company at the date of the RTO. RBx made an additional investment of $55,000 in Interactive in exchange for 1,375,000 common shares, which were consolidated into 54,525 common shares of the Company at the date of the RTO. An additional $405,000 was invested by directors and officers of the Company in exchange for 202,500 common shares as part of the share issuance in connection with the RTO, and another $55,000 was invested in Interactive by an officer of the Company in exchange for 1,375,000 common shares, which were consolidated into 54,525 common shares of the Company at the date of the RTO.

On October 18, 2023, the Company signed an agreement with RBx, that provides for certain managerial positions to be filled from within RBx. RBx is responsible for the payment and provision of all wages, bonuses, and benefits for these positions. Reimbursable salaries paid to RBx pursuant to this agreement are $100,000 per month during the year ended December 31, 2023 and $125,000 per month during the six months ended June 30, 2024. Reimbursable salaries paid to RBx were approximately $400,000 during the year ended December 31, 2023 (2022 - $nil) and were $375,000 and $675,000 during the three and six months ended June 30, 2024 (2023 - $nil and $nil). Additional expenses of $736,690, $38,770 and $124,178 were incurred by RBx on behalf of the Company during the year ended December 31, 2023 and in the three and six months ended June 30, 2024, respectively. The Company paid $970,740 to RBx during the year ended December 31, 2023 (2022 - $nil) and $491,885 and $830,028 during the three and six months ended June 30, 2024 (2023 - $nil and $nil). The total amount of accounts payable to RBx was $165,950 as of December 31, 2023 (2022 - $nil) and was $135,100